Population structure analysis of carbapenem-resistant Acinetobacter baumannii clinical isolates from Brazil reveals predominance of clonal complexes 1, 15, and 79

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2545-2547

  Camargo, Carlos Henrique ^a   Tiba, Monique Ribeiro ^a   Saes, Marta Regina ^a   De Vasconcellos, Francielli Mahnic ^a   Dos Santos, Luis Fernando ^a   Romero, Eliete Caló ^a   De Oliveira Garcia, Doroti ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE OXA-51, ACINETOBACTER BAUMANNII; CARBAPENEM DERIVATIVE; ISOENZYME;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; BROTH DILUTION; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CLONAL COMPLEX 1; CLONAL COMPLEX 15; CLONAL COMPLEX 79; CLONE; COMMUNITY STRUCTURE; GENE FREQUENCY; GENE IDENTIFICATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECIES DISTRIBUTION; ACINETOBACTER INFECTIONS; CELL CLONE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HEALTH SURVEY; HOSPITAL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PLASMID;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; CLONE CELLS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION; GENOTYPE; HOSPITALS; HUMANS; ISOENZYMES; MULTILOCUS SEQUENCE TYPING; PLASMIDS; PUBLIC HEALTH SURVEILLANCE;

EID: 84963616389     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02186-15     Document Type: Article

References (21)

1. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41:11-19. http://dx.doi.org/10.1016/j.ijantimicag.2012.09.008.
2. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. 2005. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 43:1632-1639. http://dx.doi.org/10.1128/JCM.43.4.1632-1639.2005.
3. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351-353. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.004.
5. Higgins PG, Lehmann M, Seifert H. 2010. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35:305. http://dx.doi.org/10.1016/j.ijantimicag.2009.10.014.
6. Cayô R, Merino M, Ruiz Del Castillo B, Cano ME, Calvo J, Bou G, Martínez-Martínez L. 2014. OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain. Antimicrob Agents Chemother 58:4944-4948. http://dx.doi.org/10.1128/AAC.02633-13.
7. Donald HM, Scaife W, Amyes SG, Young HK. 2000. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 44:196-199. http://dx.doi.org/10.1128/AAC.44.1.196-199.2000.
8. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. 2009. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53:5035-5038. http://dx.doi.org/10.1128/AAC.00856-09.
9. Segal H, Garny S, Elisha BG. 2005. Is IS (ABA-1) customized for Acinetobacter? FEMS Microbiol Lett 243:425-429. http://dx.doi.org/10.1016/j.femsle.2005.01.005.
10. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
11. Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 49:4174-4179. http://dx.doi.org/10.1128/AAC.49.10.4174-4179.2005.
12. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresisgenerated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328-4335. http://dx.doi.org/10.1128/JCM.43.9.4328-4335.2005.
13. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef AP, Asensi MD, Peixe L. 2011. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 66:62-65. http://dx.doi.org/10.1093/jac/dkq406.
14. Martins N, Martins IS, de Freitas WV, de Matos JA, Girão VB, Coelho-Souza T, Maralhães AC, Cacci LC, de Figueiredo MP, Dias RC, Costa-Lourenço AP, Ferreira AL, Dalla-Costa L, Nouér SA, Santoro-Lopes G, Riley LW, Moreira BM. 2013. Imported and intensive care unit-born Acinetobacter baumanniiclonal complexes: one-year prospective cohort study in intensive care patients. Microb Drug Resist 19:216-223. http://dx.doi.org/10.1089/mdr.2012.0174.
15. Chagas TP, Carvalho KR, de Oliveira Santos IC, Carvalho-Assef AP, Asensi MD. 2014. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). Diagn Microbiol Infect Dis 79:468-472. http://dx.doi.org/10.1016/j.diagmicrobio.2014.03.006.
16. Coelho-Souza T, Reis JN, Martins N, Martins IS, Menezes AO, Reis MG, Silva NO, Dias RC, Riley LW, Moreira BM. 2013. Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil. Clin Microbiol Infect 19:E241-E244. http://dx.doi.org/10.1111/1469-0691.12145.
17. Vasconcelos AT, Barth AL, Zavascki AP, Gales AC, Levin AS, Lucarevschi BR, Cabral BG, Brasiliense DM, Rossi F, Furtado GH, Carneiro IC, da Silva JO, Ribeiro J, Lima KV, Correa L, Britto MH, Silva MT, da Conceição ML, Moreira M, Martino MD, de Freitas MR, Oliveira MS, Dalben MF, Guzman RD, Cayô R, Morais R, Santos SA, Martins WM. 2015. The changing epidemiology of Acinetobacter spp. producing OXA carbapenemases causing bloodstream infections in Brazil: a BrasNet report. Diagn Microbiol Infect Dis 83:382-385. http://dx.doi.org/10.1016/j.diagmicrobio.2015.08.006.
18. Rossi F. 2011. The challenges of antimicrobial resistance in Brazil. Clin Infect Dis 52:1138-1143. http://dx.doi.org/10.1093/cid/cir120.
19. Martins N, Dalla-Costa L, Uehara AA, Riley LW, Moreira BM. 2013. Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion. Infect Genet Evol 20:378-380. http://dx.doi.org/10.1016/j.meegid.2013.09.028.
20. Pillonetto M, Arend L, Vespero EC, Pelisson M, Chagas TP, Carvalho-Assef AP, Asensi MD. 2014. First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil. Antimicrob Agents Chemother 58:7592-7594. http://dx.doi.org/10.1128/AAC.03444-14.
21. Campos J, Pereira M, Yub EA, Sampaio J. First report of NDM-1 producing Acinetobacter radioresistens and Acinetobacter ursingii from Brazil, poster EV0366. 25th Eur Congress Clin Microbiol Infect Dis.